03/13/2026
Big news: Local Infusion is the first ambulatory infusion center to join Kedrion Biopharma's limited distribution network for QIVIGY, a newly FDA-approved IVIG therapy for adults living with Primary Humoral Immunodeficiency, available this month.
Local Infusion was chosen for our unique ability to bring together infusion data, intelligent automation, and programmable care pathways to get patients treated faster, improve adherence, and deliver better outcomes.
This partnership will allow us to continue expanding patient-centered programs in collaboration with manufacturers, healthcare providers, health systems, and payors nationwide. Because patients deserve better.